In the last decade novel animal models of tauopathies have been developed that employ injection of fibrillar tau assemblies—so-called “seeds”—into the brains of tau Tg mice, resulting in accelerated induction of tau pathology [13, 31, 52]. The gene discussed is MAPT; the disease is tauopathy.